Frank A Giordano
Oncology Informatics: Status Quo and Outlook
Putora P, Baudis M, Beadle B, El Naqa I, Giordano F, Nicolay N. Oncology Informatics: Status Quo and Outlook. Oncology 2020; 98:329-331.
14.05.2020Oncology Informatics: Status Quo and Outlook
14.05.2020Oncology 2020; 98:329-331
Putora Paul Martin, Baudis Michael, Beadle Beth M, El Naqa Issam, Giordano Frank A, Nicolay Nils H
Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review
Käsmann L, Mäurer M, Panje C, Rosenbrock J, Sautter L, Schmitt D, Süß C, Thieme A, Trommer-Nestler M, Ziegler S, Ebert N, Medenwald D, Ostheimer C, Krug D, Klook L, Kaul D, Niyazi M, Blanck O, Baues C, Baumann R, Dobiasch S, Eze C, Fleischmann D, Gauer T, Giordano F, Goy Y, Hausmann J, Henkenberens C, Young DEGRO Trial Group. Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review. Strahlenther Onkol 2017; 194:79-90.
13.10.2017Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review
13.10.2017Strahlenther Onkol 2017; 194:79-90
Käsmann Lukas, Mäurer Matthias, Panje Cédric, Rosenbrock Johannes, Sautter Lisa, Schmitt Daniela, Süß Christoph, Thieme Alexander H, Trommer-Nestler Maike, Ziegler Sonia, Ebert Nadja, Medenwald Daniel, Ostheimer Christian, Krug David, Klook Lisa, Kaul David, Niyazi Maximilian, Blanck Oliver, Baues Christian, Baumann René, Dobiasch Sophie, Eze Chukwuka, Fleischmann Daniel, Gauer Tobias, Giordano Frank A, Goy Yvonne, Hausmann Jan, Henkenberens Christoph, Young DEGRO Trial Group
Axially vascularized tissue-engineered bone constructs retain their in vivo angiogenic and osteogenic capacity after high-dose irradiation.
Eweida A, Frisch O, Giordano F, Fleckenstein J, Wenz F, Brockmann M, Schulte M, Schmidt V, Kneser U, Harhaus L. Axially vascularized tissue-engineered bone constructs retain their in vivo angiogenic and osteogenic capacity after high-dose irradiation. J Tissue Eng Regen Med 2017; 12:e657-e668.
22.03.2017Axially vascularized tissue-engineered bone constructs retain their in vivo angiogenic and osteogenic capacity after high-dose irradiation.
22.03.2017J Tissue Eng Regen Med 2017; 12:e657-e668
Eweida Ahmad, Frisch Oliver, Giordano Frank A, Fleckenstein Jens, Wenz Frederik, Brockmann Marc A, Schulte Matthias, Schmidt Volker, Kneser Ulrich, Harhaus Leila